Elsevier, The Lancet HIV, 4(3), p. e183-e190, 2016
DOI: 10.1016/s2352-3018(16)00019-9
Full text: Download
HIV incidence is the best measure of treatment-programme effectiveness, but its measurement is difficult and expensive. The concept of community viral load as a modifiable driver of new HIV infections has attracted substantial attention. We set out to compare several measures of community viral load and antiretroviral therapy (ART) coverage as correlates of HIV incidence in high-risk populations.